RedHill Announces Unanimous DSMB Recommendation to Continue Ph...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, N.C., November 19, 2020, /PRNewswire-AsiaNet/-- Pre-scheduled independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia Enrollment in the 270-patient global Phase 2/3 COV...
Authors: LATEST ASIANET NEWS RELEASES